Endothelium and coronary circulation El endotelio y la circulacion coronaria.
Author
dc.contributor.author
Domenech, Cristina
Author
dc.contributor.author
Macho Fisher, Pilar
Admission date
dc.date.accessioned
2019-01-29T15:47:33Z
Available date
dc.date.available
2019-01-29T15:47:33Z
Publication date
dc.date.issued
1991
Cita de ítem
dc.identifier.citation
Revista medica de Chile, Volumen 119, Issue 2, 2018, Pages 189-196
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162402
Abstract
dc.description.abstract
In the last few years, so many different substances produced by the endothelium have been discovered that this structure is considered today a paracrine organ. Among these substances, there are at least three with marked vascular effects: prostacyclin (PGI-2) and the endothelium-derived relaxing factor (EDRF) are vasodilators, platelet stabilizers and anti-atherogenic. On the other hand, endothelin-1 (ET-1) is a potent vasoconstrictor and probably pro-atherogenic. There are many agents that stimulate the liberation of these substances by the endothelium and most of them stimulate simultaneously the production of the three substances. Even though it is not possible yet to define the exact participation of the endothelium in the normal regulation of coronary blood flow it is highly probably that a disfunction of this structure secondary to hypercholesterolemia, hypertension, atheromatosis, diabetes and smoking may decrease the coronary reserve, induce coronary spasm and facilitates the d